243 related articles for article (PubMed ID: 14515195)
1. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
López-Alemany R; Suelves M; Muñoz-Cánoves P
Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
[TBL] [Abstract][Full Text] [Related]
2. Alpha-enolase plasminogen receptor in myogenesis.
Lopez-Alemany R; Suelves M; Diaz-Ramos A; Vidal B; Munoz-Canoves P
Front Biosci; 2005 Jan; 10():30-6. PubMed ID: 15574344
[TBL] [Abstract][Full Text] [Related]
3. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
[TBL] [Abstract][Full Text] [Related]
4. Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle.
Díaz-Ramos À; Roig-Borrellas A; García-Melero A; Llorens A; López-Alemany R
PLoS One; 2012; 7(12):e50477. PubMed ID: 23239981
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
6. Alpha-enolase comes muscling in on plasminogen activation.
Miles LA; Ellis V
Thromb Haemost; 2003 Oct; 90(4):564-6. PubMed ID: 14515173
[No Abstract] [Full Text] [Related]
7. uPA deficiency exacerbates muscular dystrophy in MDX mice.
Suelves M; Vidal B; Serrano AL; Tjwa M; Roma J; López-Alemany R; Luttun A; de Lagrán MM; Díaz-Ramos A; Jardí M; Roig M; Dierssen M; Dewerchin M; Carmeliet P; Muñoz-Cánoves P
J Cell Biol; 2007 Sep; 178(6):1039-51. PubMed ID: 17785520
[TBL] [Abstract][Full Text] [Related]
8. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
9. Strong induction of the Tis11B gene in myogenic differentiation.
Busse M; Schwarzburger M; Berger F; Hacker C; Munz B
Eur J Cell Biol; 2008 Jan; 87(1):31-8. PubMed ID: 17889962
[TBL] [Abstract][Full Text] [Related]
10. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue-type plasminogen activator receptor on these cells.
Ellis V; Whawell SA
Blood; 1997 Sep; 90(6):2312-22. PubMed ID: 9310482
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
[TBL] [Abstract][Full Text] [Related]
14. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
15. Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures.
Ryten M; Yang SY; Dunn PM; Goldspink G; Burnstock G
FASEB J; 2004 Sep; 18(12):1404-6. PubMed ID: 15231720
[TBL] [Abstract][Full Text] [Related]
16. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
17. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
18. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
